Trusted health care sources and continuity of care may help reduce the risk of prostate cancer deaths in African-American men, according to a study published in the current issue of the journal Cancer. James Mohler, MD, Chair of the Department of Urology at Roswell Park Cancer Institute (RPCI), and William R. Carpenter, PhD, Department of [...]
No Comments »
Filed under: Men's Health
LITTLE FALLS, N.J. (MedPage Today) — Patients in the U.S. spent about $34 billion on complementary and alternative medicine in 2007, according to a government report.
No Comments »
Filed under: General Health News
ATLANTA (MedPage Today) — A CDC advisory committee has released a list of groups to receive priority vaccination against the 2009 H1N1 (swine flu) virus so broad it covers just over half the population.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — CME in the U.S. is not influenced by industry, the head of the Accreditation Council for Continuing Medical Education (ACCME) told senators at a Capitol Hill hearing.
No Comments »
Filed under: General Health News
HOUSTON (MedPage Today) — Children with acute lymphoblastic leukemia had a significantly greater likelihood of exposure to household pesticides compared with a control group, investigators found in a small case-control study.
No Comments »
Filed under: General Health News
SAN FRANCISCO (MedPage Today) — A novel rapid urine test for chlamydia offers accurate diagnosis for men without painful urethral swabbing, researchers said.
No Comments »
Filed under: General Health News
“As Congress struggles with a massive health care overhaul, several lobbying powerhouses - including the pharmaceutical industry and the nation’s largest advocacy group for retirees - are locked in a contentious fight over the future of biotechnology drugs,” USA Today reports in a front page package.
No Comments »
Filed under: Pharmacy News
When September 10 - 12, 2009 Where Vancouver, BC, Canada New research will be presented about peer review and [...]
No Comments »
Filed under: Pharmacy News
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced new six month safety and efficacy results from its fourth Phase II clinical trial using its proprietary, orally-active non-peptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.
No Comments »
Filed under: Pharmacy News
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, announced positive top-line efficacy results from the first of two patient cohorts in its second pivotal Phase 3 trial of the investigational compound, Ophena(TM) (ospemifene tablets), for the treatment of postmenopausal vulvovaginal atrophy (VVA). The Company has also successfully completed two long term safety extension studies from its [...]
No Comments »
Filed under: Pharmacy News
